B.J.C. van den Bosch

1.5k citations

29 papers · 1.1k indexed · 1 hit paper · h-index 14

Clinical Biochemistry top 1%
- Metabolism and Genetic Disorders 6
Immunology and Allergy top 10%
Cancer Research top 10%
Molecular Biology top 10%
- Mitochondrial Function and Pathology 12
- ATP Synthase and ATPases Research 8
- RNA modifications and cancer 3
Nephrology top 10%
Genetics
- Genomics and Rare Diseases 3
Public Health, Environmental and Occupational Health
- Acute Lymphoblastic Leukemia research 3
Cardiology and Cardiovascular Medicine
- Cardiomyopathy and Myosin Studies 3
Infectious Diseases
- HIV/AIDS drug development and treatment 3

Co-authors: Marinus J. Blok Aimée Paulussen Rick Kamps Sofia Xanthoulea Andrea Romano Rita D. Brandão Hubert J.M. Smeets I.F.M. de Coo
Cited by: Clinical Biochemistry Immunology and Allergy Cancer Research
Journals: Nucleic Acids Research (1 paper)PLoS ONE (1 paper)Brain (1 paper)
Partner nations: Netherlands Germany France

In The Last Decade

B.J.C. van den Bosch

27 papers receiving 1.0k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by B.J.C. van den Bosch

Since Specialization

Citations

This map shows the geographic impact of B.J.C. van den Bosch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.J.C. van den Bosch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.J.C. van den Bosch more than expected).

Fields of papers citing papers by B.J.C. van den Bosch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B.J.C. van den Bosch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.J.C. van den Bosch. The network helps show where B.J.C. van den Bosch may publish in the future.

Co-authorship network

The 25 scholars most cited alongside B.J.C. van den Bosch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with B.J.C. van den Bosch Line = papers co-authored together B.J.C. van den Bosch links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Recommendations for (Pharmaco)Genetic Sampling in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation Clinical and Translational Science ·Anniek Bokma,Maja Matić,Arwin Ralf,B.J.C. van den Bosch,Manfred Kayser,Ron H. N. van Schaik,Melvin Lafeber,Marieke J. H. Coenen,Florence Atrafi	2025	0
2	Implications of Tioguanine Dosing in IBD Patients with a TPMT Deficiency Metabolites ·Debbie S. Deben,Luc J. J. Derijks,B.J.C. van den Bosch,Rob H. Creemers,A. Van Nunen,Adriaan A. van Bodegraven,Dennis R. Wong	2023	0
3	Potential added value of combined DPYD/DPD genotyping and phenotyping to prevent severe toxicity in patients with a DPYD variant and decreased dihydropyrimidine dehydrogenase enzyme activity Journal of Oncology Pharmacy Practice ·Charlotte W. Ockeloen,Aron Raaijmakers,Manon Hijmans-van der Vegt,Jörgen Bierau,Judith de Vos‐Geelen,Annelieke E.C.A.B. Willemsen,B.J.C. van den Bosch,Marieke J. H. Coenen	2021	4
4	Evolution of Dihydropyrimidine Dehydrogenase Diagnostic Testing in a Single Center during an 8-Year Period of Time Current Therapeutic Research ·Marieke J. H. Coenen,Aimée Paulussen,Marc Breuer,Martijn Lindhout,Demis Tserpelis,Anja Steyls,Jörgen Bierau,B.J.C. van den Bosch	2018	10
5	Genetic defects in mtDNA-encoded protein translation cause pediatric, mitochondrial cardiomyopathy with early-onset brain disease European Journal of Human Genetics ·Rick Kamps,Radek Szklarczyk,Tom E. J. Theunissen,Debby M.E.I. Hellebrekers,Suzanne C.E.H. Sallevelt,Iris Boesten,Bart de Koning,B.J.C. van den Bosch,Gajja S. Salomons,Marisa Simas-Mendes,Robert M. Verdijk,Kees Schoonderwoerd,I.F.M. de Coo,Jo Vanoevelen,Hubert J.M. Smeets	2018	22
6	Erythrocyte Inosine triphosphatase activity: A potential biomarker for adverse events during combination antiretroviral therapy for HIV PLoS ONE ·N. Chantal Peltenburg,Jörgen Bierau,Jaap Bakker,J. Schippers,Selwyn H. Lowe,Aimée Paulussen,B.J.C. van den Bosch,Mathie P.G. Leers,Bettina E. Hansen,Annelies Verbon	2018	5
7	Rapid Resolution of Blended or Composite Multigenic Disease in Infants by Whole-Exome Sequencing The Journal of Pediatrics ·Tom E. J. Theunissen,Suzanne C.E.H. Sallevelt,Debby M.E.I. Hellebrekers,Bart de Koning,Alexandra T.M. Hendrickx,B.J.C. van den Bosch,Rick Kamps,Kees Schoonderwoerd,Radek Szklarczyk,Elvira N. M. Mulder-Den Hartog,I.F.M. de Coo,Hubert J.M. Smeets	2017	6
8	Differences in Strength and Timing of the mtDNA Bottleneck between Zebrafish Germline and Non-germline Cells Cell Reports ·Auke B.C. Otten,Tom E. J. Theunissen,Josien G. Derhaag,Ellen Lambrichs,Iris Boesten,Marie Winandy,Aafke P.A. van Montfoort,Katsiaryna Tarbashevich,Erez Raz,Mike Gerards,Jo Vanoevelen,B.J.C. van den Bosch,Marc Müller,Hubert J.M. Smeets	2016	41
9	Two Novel Mutations in the SLC25A4 Gene in a Patient with Mitochondrial Myopathy JIMD Reports ·Irene M. L. W. Körver‐Keularts,Marjolein Visser,H. D. Bakker,Ronald J. A. Wanders,Fleur Vansenne,H.R. Scholte,L. Dorland,Gerry A. F. Nicolaes,L. M. J. Spaapen,Hubert J.M. Smeets,Alexandra T.M. Hendrickx,B.J.C. van den Bosch	2015	25
10	Defective NDUFA9 as a novel cause of neonatally fatal complex I disease Journal of Medical Genetics ·B.J.C. van den Bosch,Mike Gerards,Wim J. Sluiter,Alexander P.A. Stegmann,Eveline Jongen,Debby M.E.I. Hellebrekers,Renske Oegema,Ellen Lambrichs,Holger Prokisch,Katharina Danhauser,Kees Schoonderwoerd,I.F.M. de Coo,Hubert J.M. Smeets	2011	46
11	Large scale mtDNA sequencing reveals sequence and functional conservation as major determinants of homoplasmic mtDNA variant distribution Mitochondrion ·A.M. Voets,B.J.C. van den Bosch,Alphons P. M. Stassen,Alexandra T.M. Hendrickx,Debby M.E.I. Hellebrekers,L. Van Laer,Els Van Eyken,Guy Van Camp,Angela Pyle,Simon Baudouin,Patrick F. Chinnery,Hubert J.M. Smeets	2011	6
12	Defective complex I assembly due to C20orf7 mutations as a new cause of Leigh syndrome Journal of Medical Genetics ·Mike Gerards,Wim J. Sluiter,B.J.C. van den Bosch,L. Elly A. de Wit,Chantal Calis,M. Frentzen,Hana Akbari,Kees Schoonderwoerd,H.R. Scholte,R. J. E. Jongbloed,Alexandra T.M. Hendrickx,I.F.M. de Coo,Hubert J.M. Smeets	2009	59
13	The unfolding clinical spectrum of POLG mutations Journal of Medical Genetics ·Marinus J. Blok,B.J.C. van den Bosch,Eveline Jongen,Alexandra T.M. Hendrickx,C E de Die-Smulders,Jessica E. Hoogendijk,Esther Brusse,Marjolein Visser,Bwee Tien Poll‐The,Jörgen Bierau,I.F.M. de Coo,H J Smeets	2009	61
14	Altered myocardial gene expression reveals possible maladaptive processes in heterozygous and homozygous cardiac myosin-binding protein C knockout mice Genomics ·Lars Eijssen,B.J.C. van den Bosch,Nicolas Vignier,Patrick Lindsey,C M M van den Burg,Lucie Carrier,Pieter A. Doevendans,Ger J. Vusse,Hubert J.M. Smeets	2007	11
15	Cardiac Involvement in Adults With m.3243A>G MELAS Gene Mutation The American Journal of Cardiology ·Tom Vydt,I.F.M. de Coo,Osama Soliman,Folkert J. ten Cate,Robert‐Jan van Geuns,Wim B. Vletter,Kees Schoonderwoerd,B.J.C. van den Bosch,Hubert J.M. Smeets,Marcel L. Geleijnse	2006	56
16	Early and transient gene expression changes in pressure overload-induced cardiac hypertrophy in mice Genomics ·B.J.C. van den Bosch,Patrick Lindsey,C M M van den Burg,Saskia A. van der Vlies,Daniel J. Lips,Ger J. Vusse,Torik Ayoubi,Pieter A. Doevendans,H.J.M. Smeets	2006	39
17	Increased risk for cardiorespiratory failure associated with the A3302G mutation in the mitochondrial DNA encoded tRNALeu(UUR) gene Neuromuscular Disorders ·B.J.C. van den Bosch,I.F.M. de Coo,Alexandra T.M. Hendrickx,H. F. M. Busch,G. de Jong,H.R. Scholte,Hubert J.M. Smeets	2004	19
18	Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation Kidney International ·Frank T.L. Van Der Loop,Laurence Heidet,Erika Timmer,B.J.C. van den Bosch,Anu Leinonen,Corinne Antignac,J. Ashley Jefferson,Alexander P. Maxwell,L.A.H. Monnens,Cornelis H. Schröder,Hubert J.M. Smeets	2000	104
19	Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation Kidney International ·F.T.L. van der Loop,Laurence Heidet,Erika Timmer,B.J.C. van den Bosch,Anu Leinonen,Corinne Antignac,J. Ashley Jefferson,Alexander P. Maxwell,L.A.H. Monnens,Cornelis H. Schröder,Hubert J.M. Smeets	2000	1
20	Mutation analysis of the entire mitochondrial genome using denaturing high performance liquid chromatography Nucleic Acids Research ·B.J.C. van den Bosch	2000	86

About B.J.C. van den Bosch

B.J.C. van den Bosch is a scholar working on Clinical Biochemistry, Genetics and Transplantation, having authored 29 papers that have together received 1.1k indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (12 papers), ATP Synthase and ATPases Research (8 papers), Metabolism and Genetic Disorders (6 papers), Genomics and Rare Diseases (3 papers), RNA modifications and cancer (3 papers), Acute Lymphoblastic Leukemia research (3 papers), Cardiomyopathy and Myosin Studies (3 papers) and HIV/AIDS drug development and treatment (3 papers). The work is most often cited by research in Clinical Biochemistry (279 citations), Immunology and Allergy (78 citations) and Cancer Research (186 citations). B.J.C. van den Bosch has collaborated with scholars based in Netherlands, Germany and France. Frequent co-authors include Marinus J. Blok, Aimée Paulussen, Rick Kamps, Sofia Xanthoulea, Andrea Romano, Rita D. Brandão, Hubert J.M. Smeets, I.F.M. de Coo, Mike Gerards and Alexandra T.M. Hendrickx. Their work appears in journals such as Nucleic Acids Research, PLoS ONE and Brain.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact